The potential of computational chemistry to revolutionise cancer treatment in Nigeria represents a paradigm shift in medical ...

AstraZeneca said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for ...

The 'cell of origin' of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered, in a new study in mice and humans from researchers at UCL, the ...

A Bay Area woman fights back against the odds to raise awareness about lung cancer in Asian American women who have never smoked.

Almost 50,000 lung cancer patients have not been seen on time over the last 10 years, with thousands currently waiting more ...

Relapsed/refractory (R/R) mature T and natural killer (NK)-cell lymphomas (TNKL) are aggressive blood cancers often resistant to frontline therapies. A team of Mass General Brigham researchers found ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

More than 130 passionate cancer advocates, including survivors, patients, and caregivers, converged on the state Capitol ...

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

A nurse-led intervention had a greater effect on dyspnea among patients with advanced lung cancer who experienced improvement in their psychological distress.